Skip to main content
OpenTrials
Completed

NCT Number: NCT00533663

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

To study if Healing Touch is effective during chemotherapy treatment for breast cancer

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

About this study

To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

- Stage I or II breast cancer

  • Post-operative
  • Concurrent enrollment on a treatment protocol of 8 weeks of adriamycin + cyclophosphamide given every other week followed by 8 weeks of paclitaxel given every other week
  • ECOG Performance Status: 0 to 2
  • Speak and read English

Exclusion criteria

- Previous chemotherapy exposure

  • Concomitant energy-work interventions (HT, Reiki, QiGong, acupuncture).

Treatment and study plan

Healing Touch

Procedure

every other week (during their infusion)

Standard care

Other

Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care

guided relaxation

Procedure

Primary outcomes

  1. FACT-B summary score

    Time frame: Baseline, 6 wks, 14 wks

Secondary outcomes

  1. Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale

    Time frame: Baseline, 6 wks, 14 wks

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Sep 21, 2007
Registry last updated
Jun 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.